Karen DiDonato

808 total citations
19 papers, 589 citations indexed

About

Karen DiDonato is a scholar working on Surgery, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Karen DiDonato has authored 19 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Psychiatry and Mental health. Recurrent topics in Karen DiDonato's work include Pediatric Pain Management Techniques (8 papers), Anesthesia and Pain Management (7 papers) and Sexual function and dysfunction studies (6 papers). Karen DiDonato is often cited by papers focused on Pediatric Pain Management Techniques (8 papers), Anesthesia and Pain Management (7 papers) and Sexual function and dysfunction studies (6 papers). Karen DiDonato collaborates with scholars based in United States, United Kingdom and Italy. Karen DiDonato's co-authors include Charles H. Bowden, Wesley Day, David Winslow, Pamela Pierce Palmer, Harold S. Minkowitz, Run Wang, Wayne J.G. Hellstrom, Arthur L. Burnett, Irwin Goldstein and LeRoy Jones and has published in prestigious journals such as The Journal of Urology, SLEEP and British Journal of Urology.

In The Last Decade

Karen DiDonato

19 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen DiDonato United States 12 254 210 148 138 89 19 589
Guddi Kaur United States 10 49 0.2× 101 0.5× 86 0.6× 58 0.4× 8 0.1× 10 589
Annelies E. Aquarius Netherlands 14 45 0.2× 29 0.1× 317 2.1× 71 0.5× 79 0.9× 20 637
Peter Malík Austria 13 200 0.8× 69 0.3× 53 0.4× 26 0.2× 17 0.2× 26 509
Areeg Bala United States 9 78 0.3× 58 0.3× 24 0.2× 37 0.3× 18 0.2× 16 280
A. Boshier United Kingdom 10 74 0.3× 31 0.1× 34 0.2× 20 0.1× 11 0.1× 10 382
C C Coleman United States 10 115 0.5× 44 0.2× 147 1.0× 181 1.3× 30 0.3× 21 451
José Juan Sánchez-Cruz Spain 7 562 2.2× 421 2.0× 75 0.5× 55 0.4× 250 2.8× 8 773
Nilüfer Kutay Ordu Gökkaya Türkiye 14 178 0.7× 11 0.1× 83 0.6× 40 0.3× 4 0.0× 27 608
Denis Comet France 9 72 0.3× 88 0.4× 54 0.4× 79 0.6× 192 2.2× 25 348
Maren Schmidt Germany 11 24 0.1× 54 0.3× 85 0.6× 82 0.6× 3 0.0× 18 602

Countries citing papers authored by Karen DiDonato

Since Specialization
Citations

This map shows the geographic impact of Karen DiDonato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen DiDonato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen DiDonato more than expected).

Fields of papers citing papers by Karen DiDonato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen DiDonato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen DiDonato. The network helps show where Karen DiDonato may publish in the future.

Co-authorship network of co-authors of Karen DiDonato

This figure shows the co-authorship network connecting the top 25 collaborators of Karen DiDonato. A scholar is included among the top collaborators of Karen DiDonato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen DiDonato. Karen DiDonato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hutchins, Jacob, David Leiman, Zubaid Rafique, Karen DiDonato, & Pamela Pierce Palmer. (2019). Pooled Dosing and Efficacy Analysis of the Sufentanil Sublingual Tablet 30 mcg Across Demographic Subgroups for the Management of Moderate-to-Severe Acute Pain. Journal of PeriAnesthesia Nursing. 35(1). 22–28. 8 indexed citations
2.
Miner, James R., Timothy Melson, David Leiman, et al.. (2019). Pooled Phase III Safety Analysis of Sufentanil Sublingual Tablets for Short-Term Treatment of Moderate-to-Severe Acute Pain. Pain Management. 9(3). 259–271. 17 indexed citations
3.
DiDonato, Karen, et al.. (2018). Administration of intravenous morphine for acute pain in the emergency department inflicts an economic burden in Europe. Drugs in Context. 7. 1–14. 11 indexed citations
4.
Miner, James R., Zubaid Rafique, Harold S. Minkowitz, Karen DiDonato, & Pamela Pierce Palmer. (2017). Sufentanil sublingual tablet 30 mcg for moderate-to-severe acute pain in the ED. The American Journal of Emergency Medicine. 36(6). 954–961. 26 indexed citations
5.
Hutchins, Jacob, David Leiman, Harold S. Minkowitz, et al.. (2017). An Open-Label Study of Sufentanil Sublingual Tablet 30 Mcg in Patients with Postoperative Pain. Pain Medicine. 19(10). 2058–2068. 18 indexed citations
6.
Palmer, Pamela Pierce, et al.. (2016). COST OF DELIVERING INTRAVENEOUS OPIOID ANALGESIA IN EMERGENCY DEPARTMENTS IN THE UNITED STATES. Value in Health. 19(3). A246–A247. 2 indexed citations
7.
8.
Miner, James R., Harold S. Minkowitz, Zubaid Rafique, Karen DiDonato, & Pamela Pierce Palmer. (2016). Phase 3 Efficacy and Safety Results of Sufentanil Sublingual 30 mcg Tablet for Management of Acute Traumatic Pain in Emergency Medicine. Wilderness and Environmental Medicine. 27(3). 431–431. 1 indexed citations
9.
Minkowitz, Harold S., David Leiman, Timothy Melson, et al.. (2016). Sufentanil Sublingual Tablet 30 mcg for the Management of Pain Following Abdominal Surgery: A Randomized, Placebo‐Controlled, Phase‐3 Study. Pain Practice. 17(7). 848–858. 26 indexed citations
10.
Belkoff, Laurence, A. McCullough, Irwin Goldstein, et al.. (2013). An open-label, long-term evaluation of the safety, efficacy and tolerability of avanafil in male patients with mild to severe erectile dysfunction. International Journal of Clinical Practice. 67(4). 333–341. 32 indexed citations
11.
Goldstein, Irwin, Andrew McCullough, LeRoy Jones, et al.. (2012). A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction. The Journal of Sexual Medicine. 9(4). 1122–1133. 73 indexed citations
12.
Wang, Run, Arthur L. Burnett, Kenji Omori, et al.. (2012). Selectivity of Avanafil, a PDE5 Inhibitor for the Treatment of Erectile Dysfunction: Implications for Clinical Safety and Improved Tolerability. The Journal of Sexual Medicine. 9(8). 2122–2129. 53 indexed citations
13.
14.
15.
Mulhall, John P., Arthur L. Burnett, Run Wang, et al.. (2012). A Phase 3, Placebo Controlled Study of the Safety and Efficacy of Avanafil for the Treatment of Erectile Dysfunction After Nerve Sparing Radical Prostatectomy. The Journal of Urology. 189(6). 2229–2236. 77 indexed citations
16.
Hellstrom, Wayne J.G., Ege Can Şerefoğlu, Ronald W. Lewis, et al.. (2012). 1480 ONSET OF ACTION AND TIME TO EFFICACY OF AVANAFIL, A NOVEL, RAPID-ONSET PDE5 INHIBITOR IN MEN WITH MILD TO SEVERE ERECTILE DYSFUNCTION DATA FROM PHASE 2 AND PHASE 3 CLINICAL TRIALS. The Journal of Urology. 187(4S). 4 indexed citations
17.
DiDonato, Karen, et al.. (2008). Outcomes of nonphysician vascular access and closure: a single-center clinical evaluation. Cardiovascular revascularization medicine. 9(3). 216–216. 1 indexed citations
18.
Hermiller, James, Charles A. Simonton, Tomoaki Hinohara, et al.. (2006). The StarClose® vascular closure system: Interventional results from the CLIP study. Catheterization and Cardiovascular Interventions. 68(5). 677–683. 75 indexed citations
19.
Jaff, Michael R., James Hermiller, Charles A. Simonton, et al.. (2006). The safety and efficacy of the StarClose® vascular closure system: The ultrasound substudy of the CLIP study. Catheterization and Cardiovascular Interventions. 68(5). 684–689. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guddi Kaur Breakdown of academic impact, for papers by Annelies E. Aquarius Breakdown of academic impact, for papers by Peter Malík Breakdown of academic impact, for papers by Areeg Bala Breakdown of academic impact, for papers by A. Boshier Breakdown of academic impact, for papers by C C Coleman Breakdown of academic impact, for papers by José Juan Sánchez-Cruz Breakdown of academic impact, for papers by Nilüfer Kutay Ordu Gökkaya Breakdown of academic impact, for papers by Denis Comet Breakdown of academic impact, for papers by Maren Schmidt
Rankless by CCL
2026